Moreover, besides PTEN, isolated IDC‐P cases lacking invasive carcinoma have shown an enrichment of driver mutations in other MAPK/PI3K genes, which are infrequent in conventional prostate cancer.13 This evidence concerns the gene PTEN and prostate carcinoma.